Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OneLAX is an over-the-counter (OTC) stimulant laxative syrup developed and marketed by Akron Pharma for the relief of occasional constipation. The active ingredient consists of sennosides (8.8 mg per 5 mL), which are anthraquinone glycosides derived from the senna plant. These compounds function as stimulant laxatives by increasing intestinal motility and promoting water retention within the intestines, typically inducing a bowel movement within 6 to 12 hours. The product is formulated as a chocolate-flavored oral liquid designed to provide gentle relief without harsh cramping and is categorized as a consumer healthcare product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OneLAX.